Literature DB >> 15543996

Development of an analytical reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry method for characterization of recombinant antibodies.

Thomas M Dillon1, Pavel V Bondarenko, Margaret Speed Ricci.   

Abstract

Analytical characterization of monoclonal antibodies has been hindered by the lack of appropriate chromatographic methods to be used in conjunction with high-resolution MS. Current methodologies for standard RP-HPLC are incompatible with antibodies due to irreproducibility, low recovery, short column lifetimes, and poor resolution of degradation products. An analytical RP-HPLC-MS method was developed for monitoring and characterizing intact IgG1antibodies. Key parameters required for improved chromatographic resolution included long alkyl chains of the stationary phase (Zorbax SB300 C8), column temperatures elevated to 65-70 degrees C and combination of trifluoroacetic acid and heptafluorobutyric acid ion-pairing agents. RP chromatographic separation of degradation species and C-terminal lysine variants along with the characterization of glycosylation profile by mass spectrometry demonstrates the capability of this method for whole antibody analysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15543996     DOI: 10.1016/j.chroma.2004.08.058

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  17 in total

1.  Trap for MAbs: characterization of intact monoclonal antibodies using reversed-phase HPLC on-line with ion-trap mass spectrometry.

Authors:  John C Le; Pavel V Bondarenko
Journal:  J Am Soc Mass Spectrom       Date:  2005-03       Impact factor: 3.109

2.  Molecular mass analysis of antibodies by on-line SEC-MS.

Authors:  Lowell J Brady; John Valliere-Douglass; Theresa Martinez; Alain Balland
Journal:  J Am Soc Mass Spectrom       Date:  2008-01-04       Impact factor: 3.109

3.  Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry.

Authors:  Hongcheng Liu; Georgeen Gaza-Bulseco; Chris Chumsae
Journal:  J Am Soc Mass Spectrom       Date:  2009-08-28       Impact factor: 3.109

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 5.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 6.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 7.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

8.  Fragmentation of a recombinant monoclonal antibody at various pH.

Authors:  Georgeen Gaza-Bulseco; Hongcheng Liu
Journal:  Pharm Res       Date:  2008-05-13       Impact factor: 4.200

9.  Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.

Authors:  Thomas M Dillon; Margaret Speed Ricci; Chris Vezina; Gregory C Flynn; Yaoqing Diana Liu; Douglas S Rehder; Matthew Plant; Brad Henkle; Yu Li; Songpon Deechongkit; Brian Varnum; Jette Wypych; Alain Balland; Pavel V Bondarenko
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

10.  Human IgG2 antibodies display disulfide-mediated structural isoforms.

Authors:  Jette Wypych; Ming Li; Amy Guo; Zhongqi Zhang; Theresa Martinez; Martin J Allen; Szilan Fodor; Drew N Kelner; Gregory C Flynn; Yaoqing Diana Liu; Pavel V Bondarenko; Margaret Speed Ricci; Thomas M Dillon; Alain Balland
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.